Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?

Journal article


Aryal, R. and Patabendige, A. 2021. Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes? Open Biology. 11 (4). https://doi.org/10.1098/rsob.200396
AuthorsAryal, R. and Patabendige, A.
Abstract

Atrial fibrillation (AF) has become one of the most significant health problems worldwide, warranting urgent answers to currently pending questions on the effects of AF on brain function. Recent evidence has emerged to show an association between AF and an increased risk of developing dementia and worsening of stroke outcomes. A healthy brain is protected by the blood–brain barrier (BBB), which is formed by the endothelial cells that line cerebral capillaries. These endothelial cells are continuously exposed to shear stress (the frictional force generated by blood flow), which affects endothelial cell structure and function. Flow disturbances as experienced during AF can disrupt the BBB and leave the brain vulnerable to damage. Investigating the plausible mechanisms in detail, linking AF to cerebrovascular damage is difficult in humans, leading to paucity of available clinical data. Here, we discuss the available evidence for BBB disruption during AF due to altered cerebral blood flow, and how this may contribute to an increased risk of dementia and worsening of stroke outcomes.

Year2021
JournalOpen Biology
Journal citation11 (4)
PublisherThe Royal Society
ISSN2046-2441
Digital Object Identifier (DOI)https://doi.org/10.1098/rsob.200396
Web address (URL)https://royalsocietypublishing.org/doi/10.1098/rsob.200396
Output statusPublished
Publication dates
Online21 Apr 2021
Publication process dates
Accepted29 Mar 2021
Deposited31 Jul 2025
Permalink -

https://repository.derby.ac.uk/item/qz0v1/blood-brain-barrier-disruption-in-atrial-fibrillation-a-potential-contributor-to-the-increased-risk-of-dementia-and-worsening-of-stroke-outcomes

  • 23
    total views
  • 0
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

Altered cerebrospinal fluid clearance and increased intracranial pressure in rats 18 h after experimental cortical ischaemia
Bothwell, S. W., Omileke, D., Hood, R. J., Pepperall, G-D., Azarpeykan, S., Patabendige, A. and Spratt, N. J. 2025. Altered cerebrospinal fluid clearance and increased intracranial pressure in rats 18 h after experimental cortical ischaemia. Brain Disease Mechanisms. 14, pp. 1-12. https://doi.org/10.3389/fnmol.2021.712779
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
Patabendige, A. 2023. ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Cancer Research. 83 (14), p. 2421–2437. https://doi.org/10.1158/0008-5472.CAN-23-0186
Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options
Patabendige, A. 2023. Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options. European Journal of Neuroscience. 59 (6), pp. 1359-1385. https://doi.org/10.1111/ejn.16229
The role of the blood-brain barrier during neurological disease and infection
Patabendige, A. and Janigro, D. 2023. The role of the blood-brain barrier during neurological disease and infection. Biochemical Society Transactions. 51 (2), p. 613–626. https://doi.org/10.1042/BST20220830
Astrocytic aquaporin 4 subcellular translocation as a therapeutic target for cytotoxic edema in ischemic stroke
Patabendige, A. 2022. Astrocytic aquaporin 4 subcellular translocation as a therapeutic target for cytotoxic edema in ischemic stroke. Neural Regeneration Research. 17 (12), pp. 2666-2668. https://doi.org/10.4103/1673-5374.339481
Editorial: Cerebrospinal fluid dynamics and intracranial pressure elevation-Novel insights on molecular and physiological mechanisms, and implications for neurological disease
Patabendige, A. 2022. Editorial: Cerebrospinal fluid dynamics and intracranial pressure elevation-Novel insights on molecular and physiological mechanisms, and implications for neurological disease. Frontiers in Molecular Neuroscience. 15. https://doi.org/10.3389/fnmol.2022.1119980
Short-duration hypothermia induction in rats using Models for Studies examining clinical relevance and mechanisms
Patabendige, A. 2021. Short-duration hypothermia induction in rats using Models for Studies examining clinical relevance and mechanisms. Journal of Visualized Experiments. 169. https://doi.org/10.3791/62325
Astrocyte activation in neurovascular damage and repair following ischaemic stroke
Patabendige, A. 2021. Astrocyte activation in neurovascular damage and repair following ischaemic stroke. International Journal of Molecular Sciences. 22 (8), pp. 1-22. https://doi.org/10.3390/ijms22084280
Ultra-short duration hypothermia prevents intracranial pressure elevation following ischaemic stroke in rats
Patabendige, A. 2021. Ultra-short duration hypothermia prevents intracranial pressure elevation following ischaemic stroke in rats. Frontiers in Neurology. 12, pp. 1-9. https://doi.org/10.3389/fneur.2021.684353
Short-duration hypothermia completed prior to reperfusion prevents intracranial pressure elevation following ischaemic stroke in rats
Patabendige, A. 2021. Short-duration hypothermia completed prior to reperfusion prevents intracranial pressure elevation following ischaemic stroke in rats. Scientific Reports. 11, pp. 1-9. https://doi.org/10.1038/s41598-021-01838-7
Decreased intracranial pressure elevation and cerebrospinal fluid outflow resistance: a potential mechanism of hypothermia cerebroprotection following experimental stroke
Patabendige, A. 2021. Decreased intracranial pressure elevation and cerebrospinal fluid outflow resistance: a potential mechanism of hypothermia cerebroprotection following experimental stroke. Brain Sciences. 11 (12), pp. 1-10. https://doi.org/10.3390/brainsci11121589
CSF secretion is not altered by NKCC1 Nor TRPV4 antagonism in healthy rats
Patabendige, A. 2021. CSF secretion is not altered by NKCC1 Nor TRPV4 antagonism in healthy rats. Brain Sciences. 11 (9), pp. 1-13. https://doi.org/10.3390/brainsci11091117